Clinical trial
Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation
NCT00349401 · Wake Forest University Health Sciences, Other · Withdrawn
Key facts
| NCT number | NCT00349401 |
|---|---|
| Title | Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation |
| Official title | Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | ketorolac, morphine |
| Enrollment | 0 |
| Start date | Dec 1, 2006 |
| First posted | Jul 7, 2006 |
| Last update posted | Nov 6, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: